These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
356 related items for PubMed ID: 24417782
1. The Australian experience with the human papillomavirus vaccine. Garland SM. Clin Ther; 2014 Jan 01; 36(1):17-23. PubMed ID: 24417782 [Abstract] [Full Text] [Related]
3. Human papillomavirus vaccine introduction--the first five years. Markowitz LE, Tsu V, Deeks SL, Cubie H, Wang SA, Vicari AS, Brotherton JM. Vaccine; 2012 Nov 20; 30 Suppl 5():F139-48. PubMed ID: 23199957 [Abstract] [Full Text] [Related]
4. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Garland SM, Skinner SR, Brotherton JM. Prev Med; 2011 Oct 20; 53 Suppl 1():S29-35. PubMed ID: 21962468 [Abstract] [Full Text] [Related]
7. Implementation of human papillomavirus immunization in the developing world. Kane MA, Serrano B, de Sanjosé S, Wittet S. Vaccine; 2012 Nov 20; 30 Suppl 5():F192-200. PubMed ID: 23199963 [Abstract] [Full Text] [Related]
8. Post-licensure monitoring of HPV vaccine in the United States. Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF. Vaccine; 2010 Jul 05; 28(30):4731-7. PubMed ID: 20188681 [Abstract] [Full Text] [Related]
9. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma. Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, Netterlid E, Sparén P, Arnheim-Dahlström L. JAMA; 2014 Feb 12; 311(6):597-603. PubMed ID: 24519299 [Abstract] [Full Text] [Related]
11. How to best measure the effectiveness of male human papillomavirus vaccine programmes? Garland SM, Molesworth EG, Machalek DA, Cornall AM, Tabrizi SN. Clin Microbiol Infect; 2015 Sep 12; 21(9):834-41. PubMed ID: 26055415 [Abstract] [Full Text] [Related]
12. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC. Vaccine; 2013 Aug 20; 31(37):3863-71. PubMed ID: 23830974 [Abstract] [Full Text] [Related]
15. Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males. Korostil IA, Ali H, Guy RJ, Donovan B, Law MG, Regan DG. Sex Transm Dis; 2013 Nov 20; 40(11):833-5. PubMed ID: 24113401 [Abstract] [Full Text] [Related]
16. Prevention strategies against the human papillomavirus: the effectiveness of vaccination. Stanley M. Gynecol Oncol; 2007 Nov 20; 107(2 Suppl 1):S19-23. PubMed ID: 17938013 [Abstract] [Full Text] [Related]